CIDRAP newsletters options
High-risk adults with mild to moderate COVID-19 who receive a dose of casirivimab and imdevimab have lower hospitalization rates than those who don't, according to a randomized, controlled trial today in The Lancet's EClinicalMedicine. The casirivimab and imdevimab combination is under emergency use authorization by the US Food and Drug Administration.
A new report from the World Economic Forum predicts a future of rising risks and costs from waterborne antimicrobial resistance (AMR).
A third still have shortness of breath 1 year after hospital release.
Also, the CDC does not intend to revisit its pre-Delta COVID-19 guidelines for schools at this point.
After recall of the Pfizer drug, Apotex and Par Pharmaceutical are tapped to increase supply.
Officials are hopeful Africa can reach 10% of its population with vaccine by the end of September.
The risk of blood clots is higher following COVID-19 infection than after vaccination, researchers based at Oxford University reported today in BMJ.
A quality improvement (QI) program combining clinician education, clear and concise recommendations, and decision support was associated with a safe reduction in vancomycin use in a pediatric intensive care unit (PICU), researchers reported today in Pediatrics.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Also, Vietnam is sending troops to help with a surge in one of its main manufacturing hubs.
Any slight risk tied to the vaccine was a much higher risk among those infected with COVID-19.
The amount of resistance genes found in DNA from brown bears mirrored the rise of antibiotic use in Sweden.
In addition, the CDC warns about ivermectin, a livestock anti-parasite drug some people have used to treat COVID-19.
Supply chains were affected by both nationalism and international interdependence.
US veteran suicide ideation (SI) rates showed a slight decrease during the first year of the pandemic, according to a JAMA Psychiatry study yesterday. Among the associated risks, however, was having COVID-19, which doubled the odds of SI.
"After declining in early summer, child cases have increased exponentially."
Venous thromboembolism is nearly twice as likely in those with recent COVID-19.
Also, a US probe into the source of SARS-CoV-2 was inconclusive, with worries that time is running out to discover the origin.
Substance use among US kids 10 to 14 years old remained relatively stable during the first 6 months of the pandemic, according to longitudinal study results published yesterday in the Journal of Adolescent Health.
And those not vaccinated are 29 times more likely to be hospitalized for COVID.
